Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Neurology Asia
>
2020
>
25
>
4
Volume:
25
Issue:
4
1. Epilepsy in Southeast Asia, how much have we closed the management gap in past two decades?
Page:425—438
2. Efficacy and safety of endovascular treatment vs medical treatment in anterior circulation stroke beyond 6 Hours: A systematic review and metaanalysis
Page:439—446
3. Clinical predictors of early neurological deterioration in patients with acute minor ischemic stroke
Page:447—451
4. The study of intermediate-term survival of the patients with cerebral venous sinus thrombosis
Page:453—457
5. Does the presence of ideomotor apraxia in stroke patients adversely affect rehabilitation outcomes? A prospective study
Page:459—465
6. How many more seizure remission can we achieve with epilepsy surgeries in a general epilepsy population?
Page:467—472
7. Varicella and isolated acute peripheral facial nerve palsy: A systematic review on natural history, prognosis and treatment
Page:473—484
8. Covid-19 perception and self reported impact of pandemic on Parkinson’s disease symptoms of patients with physically independent Parkinson’s disease
Page:485—491
9. Assessment of visual evoked potentials in migraineurs: A cross-sectional study
Page:493—500
10. White matter hyperintensities and carotid intima media thikness In migraine without aura patients
Page:501—508
11. Efficacy and safety of pregabalin for chronic neuropathic pain: A meta-analysis
Page:509—517
12. Medical hypnotic management associated with drug dependence in patients with insomnia and neurological disorders
Page:519—526
13. Development and validation of a novel survival model for glioblastoma based on glycolysis-related genes
Page:527—534
14. Stem cell therapy in improving the motor function of patients with cerebral palsy: Systematic review with meta-analysis
Page:535—544
15. Maintaining stroke care in the era of Covid-19: A review of practices implemented in the Gulf and Iran
Page:545—533
16. The pattern and burden of neurological disorders: A systemic review of Neurology Department, Yangon General Hospital, Myanmar
Page:555—561
17. Reversible Parinaud’s syndrome during the first 24 hours following a transient ischemic attack – A case report and review of literature
Page:563—568
18. Endovascular treatment of acute basilar artery occlusion with a distal intracranial aneurysm: A case report and literature review
Page:569—574
19. Anti-N-methyl-D-aspartate receptor encephalitis associated with acute Epstein–Barr virus infection: A case report
Page:575—580
20. Case series of three Filipino siblings diagnosed with Thomsen disease with T310M missense mutation
Page:581—586
21. CLCN1 mutations could lead to atypical myotonic symptoms and abnormities on electromyography
Page:587—592
22. Marked hemiatrophy caused by a nonsense mutation of the dystrophin gene in a female patient of Duchenne muscular dystrophy
Page:593—596
23. Childhood-onset demyelinating polyneuropathy: challenges in differentiating acquired from genetic disease
Page:597—602
24. Total recovery of a patient with psychogenic parkinsonism and the diagnostic utility of contralateral pronation-supination task during EMG recording
Page:603—606
25. COVID-19 infection presenting with acute thalamic infarction in a patient with Fahr’s disease
Page:607—610
26. Airplane headache: An atypical case with autonomic symptoms and long duration
Page:611—613
27. Reversible splenial lesion syndrome (RESLES) associated with NMDAR antibody type autoimmune encephalitis
Page:615—617
28. Cervical spinal ependymoma in a child with Down syndrome: A case report and review of the literature
Page:619—621
29. Variant nonketotic hyperglycinemia caused by a novel pathogenic mutation in the GLRX5 gene
Page:623—626
30. Acute acro-paraesthesia and bilateral clumsy hand syndrome rare presenting manifestation of vitamin B12 deficiency: a case report highlighting clinicoradiological findings at diagnosis and follow-up
Page:627—630
31. Interhemispheric disconnection due to Marchiafava– Bignami disease
Page:631—634
32. Effectiveness of dopaminergic drugs on post stroke recovery: Challenges and new insights
Page:635—637